A working classification of scleroderma spectrum disorders: A proposal and the results of testing on a sample of patients

Clinical and Experimental Rheumatology

Volumn 22, Issue 3 SUPPL. 33, 2004, Pages

  Maricq, Hildegard Rand ^a   Valter, Ivo ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Center for Clinical and Basic Research   (Estonia)

Author keywords

Autoantibodies; Classification; CREST; Microvasculature; Raynaud's phenomenon; Scleroderma; Telangiectases

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MICROVASCULARIZATION; PATIENT CODING; PATIENT REFERRAL; PRIORITY JOURNAL; RHEUMATOLOGY; SAMPLE SIZE; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; AGE; AMERICAN COLLEGE OF RHEUMATOLOGY; BLEEDING; ESOPHAGUS; HEART; KIDNEY; LUNG; NAILFOLD CAPILLARY HEMORRHAGE; RACE; RAYNAUD PHENOMENON; SCLERODERMA; SCLERODERMA SPECTRUM DISORDER; SEX; TELANGIECTASIA;

AUTOANTIBODIES; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VASCULAR DISEASES;

EID: 4444321458     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MASI AT, RODNAN GP, MEDSGER TA Jr et al. (Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee): Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
2. GIORDANO M, VALENTINI G, MIGLIARESI S et al.: Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986; 13: 911-6.
3. BARNETT AJ, MILLER MH, LITTLEJOHN GO: A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): The value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988; 15: 276-83.
4. MASI AT: Classification of systemic sclerosis (scleroderma): Relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988; 15: 894-8.
5. FERRI C, VALENTINI G, COZZI F et al, for the Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSE): Demographic, clinical and serological features and survival in 1,012 Italian patients. Medicine 2002; 81: 139-53.
6. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD J-P, ROUSSIN A, RICH E, GOULET J-R, RAYMOND Y, SENECAL J-L: Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French-Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002; 81: 154-67.
7. FERRI C, BERNINI L, CECCHETTI R, LATORRACA A, MAROTTA G, PASERO G, NERI R, BOMBARDIERI S: Cutaneous and serological subsets of systemic sclerosis. J Rheumatol 1991; 18: 1826-32.
8. MEDSGER TA, STEEN VD: Classification, Prognosis. In CLEMENTS PG and FURST DE (Eds.): Systemic Sclerosis. Baltimore, Williams and Wilkins 1996; Chapter 3: 51-64.
9. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
10. LeROY EC, MEDSGER TA Jr: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
11. WINTERBAUER RH: Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly, and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp 1964; 114: 361-83.
12. MARICQ HR: The microcirculation in scleroderma and allied diseases. Adv Microcirc 1982; 10: 17-52.
13. MARICQ HR, HARPER FE, KHAN MM, TAN EM, LeROY EC: Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195-205.
14. MARICQ HR: Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 1986; 32: 271-6.
15. MARICQ HR: Nailfold capillary photography. Prog Appl Microcirc 1986; 11: 11-27.
16. MARICQ HR, WEINRICH MC, KEIL JE et al.: Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32: 998-1006.
17. MARICQ HR: Capillaroscopy in Raynaud's syndrome. Vascular Medicine Review 1992; 3: 3-20.
18. MARICQ HR, SMITH EA: Organ involvement: peripheral vascular. In CLEMENTS PG and FURST DE (Eds.): Systemic Sclerosis. Baltimore, Williams and Wilkins, 1996; Chapter 17: 365-87.
19. MONIN A, REGGI M: Enquête étiologique d'un phénomène de Raynaud. Artères et Veines 1985; 4: 303-9.
20. PRIOLLET P, VAYSSAIRAT M, HOUSSET E: How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. Am J Med 1987; 83: 494-8.
21. BIERBRAUER von AFG, MENNEL HD, SCHMIDT JA, WICHERT von P: Intravital microscopy and capillaroscopically guided nail fold biopsy in scleroderma. Ann Rheum Dis 1996; 55: 305-10.
22. KABASAKAL Y, ELVINS DM, RING EFJ, McHUGH NJ: Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55: 507-12.
23. CUTOLO M, SULLI A, PIZZORNI C, SILVANO A: Nailfold videocapillarscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-60.
24. FRITZLER MJ, KINSELLA TD: The CREST syndrome: a distinct serologic entity with anti-centromere antibodies. Am J Med 1980; 69: 520-6.
25. TAN EM, RODNAN GP, GARCIA I, MOROI Y, FRITZLER MJ, PEEBLES C: Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 1980; 23: 617-25.
26. WEINER ES, HILDEBRANDT S, SENÉCAL JL et al.: Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991; 34: 68-77.
27. JABLONSKA S: Scleroderma and Pseudoscleroderma. Warsaw, Polish Medical Publishers, 1975.
28. DUHRING LA: A Practical Treatise on Diseases of the Skin. J.B. Lippincott Co., Philadelphia. 1881, pg. 369, cited by RODNAN GP and BENEDEK TG: An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 1962; 57: 305-19.
29. MARICQ HR: Capillary ahnomalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol 1992; 128: 630-2.
30. SELLEI J: The Akrosklerosis (Sklerodaktylie) und deren Symptomen - komplex nebst neueren Untersuchungen bei Sklerodermie. Arch Derm Syph 1931; 163: 343, cited by RODNAN GP and BENEDEK TG: An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 1962; 57: 305-19.
31. CROWN S: Visceral scleroderma without skin involvement. Br Med J 1961; 2: 1541-43.
32. RODNAN CP, FENNELL RH: Progressive systemic sclerosis sine scleroderma. JAMA 1962; 180: 665-70.
33. VALENTINI G, MEDSGER TA Jr, SILMAN AJ, BOMBARDIERI S: Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S47-8.